Skip to main content

Advertisement

Log in

Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/objectives

This study aims to evaluate the role of fat free mass index (FFMI) and phase angle (PhA) as markers to predict occurrence of new digital ulcers in systemic sclerosis (SSc) patients.

Methods

Body composition evaluation from bioelectrical impedance and clinical assessment were performed in SSc patients at enrollment and after 12 months follow-up.

Results

Seventy-nine SSc patients (67 female) with a mean age of 53 ± 13 years were enrolled. In SSc patients with a digital ulcers history, FFMI value is lower (p < 0.05) and phase angle (PhA) value is higher (p < 0.01) than SSc patients without a digital ulcers history. After 12 months of follow-up, 30 patients (38%) presented at least one new episode of digital ulcers. Patients with reduced FFMI had a relative risk of 6.7 for new digital ulcers (CI 2.1–21.8, p < 0.001). Patients with reduced PhA had a relative risk of 10.1 for new digital ulcers (CI 3.5–29.5, p < 0.0001). In multivariate analysis, FFMI and PhA were associated with major vascular complication (digital ulcers, pulmonary arterial hypertension, and scleroderma renal crisis). FFMI loss, assessed as delta between follow-up and baseline, is higher in SSc with short duration (≤ 3 years) than SSc patients with long duration [0.4 (0–0.50) vs − 0.10 (− 0.2–0)].

Conclusion

In SSc patients, reduction of the FFMI and PhA represents after 12 months a risk factor for development of new digital ulcers and major vascular complication.

Key Points

Fat free mass index represents a risk factor for development of digital ulcers

Phase angle represents a risk factor for development of digital ulcers

Body compositions in systemic sclerosis are a marker of activity disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Campbell PM, LeRoy EC (1975) Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4:351–368

    Article  CAS  PubMed  Google Scholar 

  2. Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390:1685–1699

    Article  PubMed  Google Scholar 

  3. Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C (2013) Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol 32:1037–1044

    Article  PubMed  Google Scholar 

  4. Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, Riemekasten G, Müller-Werdan U, Norman K (2018) Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition 55-56:51–55

    Article  PubMed  Google Scholar 

  5. Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957

    Article  PubMed  Google Scholar 

  6. Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C (2018) Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmun Rev 17:155–164

    Article  PubMed  Google Scholar 

  7. Caramaschi P, Martinelli N, Volpe A, Pieropan S, Tinazzi I, Patuzzo G, Mahamid H, Bambara LM, Biasi D (2009) A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost. Clin Rheumatol 28:807–813

    Article  PubMed  Google Scholar 

  8. Rosato E, Barbano B, Gigante A, Molinaro I, Quarta S, Pisarri S, Amoroso A, Cianci R, Salsano F (2014) Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis. Arthritis Care Res (Hoboken) 66:1380–1385

    Article  Google Scholar 

  9. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747

    Article  PubMed  PubMed Central  Google Scholar 

  10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202–205

    CAS  PubMed  Google Scholar 

  11. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285

    CAS  PubMed  Google Scholar 

  12. Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167

    PubMed  Google Scholar 

  13. Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270–276

    Article  CAS  PubMed  Google Scholar 

  14. Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, Conforti ML, Kaloudi O, Nacci F, Sacu O, Candelieri A, Pignone A, Rasero L, Conforti D, Matucci-Cerinic M (2010) Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 49:1374–1382

    Article  Google Scholar 

  15. Cederholm T, Bosaeus I, Barazzoni R, Bauer J, van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MAE, Singer P (2015) Diagnostic criteria for malnutrition: an ESPEN consensus statement. Clin Nutr 34:335–340

    Article  CAS  PubMed  Google Scholar 

  16. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Fanelli FR, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159

    Article  CAS  PubMed  Google Scholar 

  17. Caimmi C, Caramaschi P, Venturini A, Bertoldo E, Vantaggiato E, Viapiana O, Ferrari M, Lippi G, Frulloni L, Rossini M (2018) Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis. Clin Rheumatol 37:987–997

    Article  CAS  PubMed  Google Scholar 

  18. Spanjer MJ, Bultink IEM, de van der Schueren MAE, Voskuyl AE (2017) Prevalence of malnutrition and validation of bioelectrical impedance analysis for the assessment of body composition in patients with systemic sclerosis. Rheumatology (Oxford) 56:1008–1012

    Article  Google Scholar 

  19. Matsubara Y, Matsumoto T, Aoyagi Y, Tanaka S, Okadome J, Morisaki K, Shirabe K, Maehara Y (2015) Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 61:945–950

    Article  PubMed  Google Scholar 

  20. Brown JC, Harhay MO, Harhay MN (2016) Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle 7:290–298

    Article  PubMed  Google Scholar 

  21. Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393:2636–2646

    Article  PubMed  Google Scholar 

  22. Hughes M, Herrick AL (2017) Digital ulcers in systemic sclerosis. Rheumatology (Oxford) 56:14–25

    Article  CAS  Google Scholar 

  23. Hendrickse P, Degens H (2019) The role of the microcirculation in muscle function and plasticity. J Muscle Res Cell Motil 40:127–140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Díaz BB, González DA, Gannar F, Pérez MCR, de León AC (2018) Myokines, physical activity, insulin resistance and autoimmune diseases. Immunol Lett 203:1–5

    Article  PubMed  Google Scholar 

  25. Gigante A, Margiotta D, Navarini L, Barbano B, Gasperini ML, D'Agostino C, Amoroso A, Afeltra A, Rosato E (2018) Serum level of endostatin and digital ulcers in systemic sclerosis patients. Int Wound J 15:424–428

    Article  PubMed  PubMed Central  Google Scholar 

  26. Cheng Q, Hu J, Yang P, Cao X, Deng X, Yang Q, Liu Z, Yang S, Goswami R, Wang Y, Luo T, Liao K, Li Q (2017) Sarcopenia is independently associated with diabetic foot disease. Sci Rep 7:8372

    Article  PubMed  PubMed Central  Google Scholar 

  27. Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107:931–936

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Viertel M, Bock C, Reich M, Löser S, Plauth M (2019) Performance of CT-based low skeletal muscle index, low mean muscle attenuation, and bioelectric impedance derived low phase angle in the detection of an increased risk of nutrition related mortality. Clin Nutr 38:2375–2380

    Article  PubMed  Google Scholar 

  29. Selberg O, Selberg D (2002) Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 86:509–516

    Article  CAS  PubMed  Google Scholar 

  30. Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C (1996) Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 50:2103–2108

    Article  CAS  PubMed  Google Scholar 

  31. Faisy C, Rabbat A, Kouchakji B, Laaban JP (2000) Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 26:518–525

    Article  CAS  PubMed  Google Scholar 

  32. Tanaka S, Ando K, Kobayashi K et al (2019) Low bioelectrical impedance phase angle is a significant risk factor for frailty. Biomed Res Int:6283153

  33. Gigante A, Gasperini ML, Iacolare A, Fegatelli DA, Villa A, Muscaritoli M, Rosato E (2020) Phase angle in systemic sclerosis: a marker for pulmonary function and disease severity. Clin Rheumatol 39:1699–1701. https://doi.org/10.1007/s10067-020-05034-2

    Article  PubMed  Google Scholar 

  34. Gigante A, Gasperini ML, Rosato E, Navarini L, Margiotta D, Afeltra A, Muscaritoli M (2020) Phase angle could be a marker of microvascular damage in systemic sclerosis. Nutrition 73:110730

    Article  PubMed  Google Scholar 

  35. Baron M, Hudson M, Steele R, Canadian Scleroderma Research Group (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:2737–2743

    Article  PubMed  Google Scholar 

  36. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, Haehling S, Coats AJS, Anker SD (2019) Sarcopenia: a time for action. An SCWD Position Paper J Cachexia Sarcopenia Muscle 10:956–996

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edoardo Rosato.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rosato, E., Gigante, A., Iacolare, A. et al. Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients. Clin Rheumatol 39, 3693–3700 (2020). https://doi.org/10.1007/s10067-020-05141-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05141-0

Keywords

Navigation